Abstract
The present paper examines major evidences on the correlation between pre-diabetes, diabetes and cardiovascular risk, especially focusing on early and multifactorial treatment strategies holding the potential to delay the occurrence of micro- and macro-vascular complications causing impaired quality of life and reduced survival.
Keywords: Glucose abnormalities, pre-diabetes, diabetes, macro-vascular and micro-vascular disease, prevention, cardiovascular risk
Current Vascular Pharmacology
Title:Impact of Pre-Diabetes and Diabetes on Cardiovascular Outcomes
Volume: 10 Issue: 6
Author(s): Matteo Anselmino and Dario Sillano
Affiliation:
Keywords: Glucose abnormalities, pre-diabetes, diabetes, macro-vascular and micro-vascular disease, prevention, cardiovascular risk
Abstract: The present paper examines major evidences on the correlation between pre-diabetes, diabetes and cardiovascular risk, especially focusing on early and multifactorial treatment strategies holding the potential to delay the occurrence of micro- and macro-vascular complications causing impaired quality of life and reduced survival.
Export Options
About this article
Cite this article as:
Anselmino Matteo and Sillano Dario, Impact of Pre-Diabetes and Diabetes on Cardiovascular Outcomes, Current Vascular Pharmacology 2012; 10 (6) . https://dx.doi.org/10.2174/157016112803520882
DOI https://dx.doi.org/10.2174/157016112803520882 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Advancements in Arterial Stiffness: Novel Therapeutic Frontiers
Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Your Father and Grandfather’s Atrial Fibrillation: A Review of the Genetics of the Most Common Pathologic Cardiac Dysrhythmia
Current Genomics The Biology and Therapeutic Potential of the DDAH/ADMA Pathway
Current Pharmaceutical Design Nutrient Content of Lettuce and its Improvement
Current Nutrition & Food Science Pulmonary Vascular Function in Insulin Resistance and Diabetes
Current Vascular Pharmacology Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)
Current Pharmaceutical Design Nanotechnology Based Diagnostic and Therapeutic Strategies for Neuroscience with Special Emphasis on Ischemic Stroke
Current Medicinal Chemistry Treatment of Atherosclerotic Renovascular Disease
Current Hypertension Reviews Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
Current Drug Targets Molecular Mechanisms Involved in the Aging of the T-cell Immune Response
Current Genomics Impact of High Protein Intake on Viral Load and Hematological Parameters in HIV-infected Patients
Current HIV Research Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs
Current Drug Targets Cytochrome P450 2C8 and Drug Metabolism
Current Topics in Medicinal Chemistry Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
Current Vascular Pharmacology Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Cardiovascular & Hematological Disorders-Drug Targets Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Long-Acting Antipsychotic Medications
Current Drug Targets Mitochondria-Targeted Drugs
Current Molecular Pharmacology COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Cardiovascular Remodeling Induced by Passive Smoking
Inflammation & Allergy - Drug Targets (Discontinued)